HR 2038 · 116th Congress 2019–2021, ended

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

Latest action · May 15, 2019 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 2, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.

Cosponsors 2

Members who signed on, in the order they did. Signatures ran from Apr 15, 2019 to Oct 17, 2019.

SeatCosponsorSigned on
R-NCTed BuddApr 15, 2019
R-AZDebbie LeskoOct 17, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseJudiciary Committee
Referred Apr 2, 2019
Administrative State, Regulatory Reform, and Antitrust Subcommittee
Referred May 15, 2019

Actions 3

Everything that happened, newest first.

  1. May 15, 2019Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
  2. Apr 2, 2019Introduced in House
  3. Apr 2, 2019Referred to the House Committee on the Judiciary.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 3 ``The Congress shall have Power To . . . regulate Commerce . . . among the several States . . . .''

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 57, April 2, 2019, page H2987.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 4796Fair Care Act of 2020Related billOct 5, 2020
HR 8527Fair Care Act of 2020Related billOct 2, 2020

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To allow State-based, market-oriented, prescription drug negotiations to lower pharmaceutical drug prices, to encourage competition, to increase consumer choice and access, and for other purposes.
Short Title(s) as Introduced
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 2, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.